• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院中日益严重的威胁:多重耐药鲍曼不动杆菌。

An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

作者信息

Dijkshoorn Lenie, Nemec Alexandr, Seifert Harald

机构信息

Department of Infectious Diseases C5-P, Leiden University Medical Centre, Albinusdreef 2, P.O. BOX 9600, 2300 RC Leiden, The Netherlands.

出版信息

Nat Rev Microbiol. 2007 Dec;5(12):939-51. doi: 10.1038/nrmicro1789.

DOI:10.1038/nrmicro1789
PMID:18007677
Abstract

Since the 1970s, the spread of multidrug-resistant (MDR) Acinetobacter strains among critically ill, hospitalized patients, and subsequent epidemics, have become an increasing cause of concern. Reports of community-acquired Acinetobacter infections have also increased over the past decade. A recent manifestation of MDR Acinetobacter that has attracted public attention is its association with infections in severely injured soldiers. Here, we present an overview of the current knowledge of the genus Acinetobacter, with the emphasis on the clinically most important species, Acinetobacter baumannii.

摘要

自20世纪70年代以来,多重耐药(MDR)不动杆菌菌株在重症住院患者中的传播以及随后的流行,已成为日益令人担忧的原因。在过去十年中,社区获得性不动杆菌感染的报告也有所增加。MDR不动杆菌最近引起公众关注的一种表现是它与重伤士兵的感染有关。在这里,我们概述了不动杆菌属的当前知识,重点是临床上最重要的物种鲍曼不动杆菌。

相似文献

1
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.医院中日益严重的威胁:多重耐药鲍曼不动杆菌。
Nat Rev Microbiol. 2007 Dec;5(12):939-51. doi: 10.1038/nrmicro1789.
2
Acinetobacter baumannii: an emerging multidrug-resistant threat.鲍曼不动杆菌:一种新出现的多重耐药威胁。
Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309.
3
Confronting multidrug-resistant Acinetobacter baumannii: a review.应对多重耐药鲍曼不动杆菌:综述。
Int J Antimicrob Agents. 2011 Feb;37(2):102-9. doi: 10.1016/j.ijantimicag.2010.10.014. Epub 2010 Dec 4.
4
Acinetobacter baumannii resistant to everything: what should we do?对所有药物均耐药的鲍曼不动杆菌:我们该怎么办?
Clin Microbiol Infect. 2011 Jul;17(7):955-6. doi: 10.1111/j.1469-0691.2011.03566.x.
5
Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.由鲍曼不动杆菌引起的社区获得性血流感染:一项匹配病例对照研究。
J Microbiol Immunol Infect. 2018 Oct;51(5):629-635. doi: 10.1016/j.jmii.2017.02.004. Epub 2017 Jun 29.
6
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.鲍曼不动杆菌对碳青霉烯类药物耐药性的出现:临床影响和治疗选择。
Int J Antimicrob Agents. 2012 Feb;39(2):105-14. doi: 10.1016/j.ijantimicag.2011.10.004. Epub 2011 Nov 22.
7
An Increasing Threat in an Iranian Referral Children's Hospital: Multidrug-Resistant Acinetobacter baumannii.伊朗一家转诊儿童医院面临的日益严重的威胁:多重耐药鲍曼不动杆菌。
Infect Disord Drug Targets. 2018;18(2):129-135. doi: 10.2174/1871526517666170113144541.
8
Molecular epidemiology of multidrug-resistant clinical isolates of Acinetobacter baumannii : A 10-year analysis in a large tertiary care university hospital in central Europe with international admissions.多药耐药临床分离鲍曼不动杆菌的分子流行病学:中欧一家大型三级教学医院的 10 年分析,包括国际收治患者。
Wien Klin Wochenschr. 2017 Nov;129(21-22):816-822. doi: 10.1007/s00508-017-1242-7. Epub 2017 Aug 3.
9
Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.波兰一家三级护理医院中耐碳青霉烯鲍曼不动杆菌菌株的出现与传播
Clin Microbiol Infect. 2007 May;13(5):490-6. doi: 10.1111/j.1469-0691.2007.01694.x. Epub 2007 Feb 28.
10
Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal.尼泊尔一家大学医院耐多药鲍曼不动杆菌分离株中因armA甲基化酶导致的氨基糖苷类耐药性的出现
J Nepal Health Res Counc. 2016 May;14(33):72-76.

引用本文的文献

1
Linarin and Hyperoside Inhibit lptD/msbA to Disrupt Membranes of Multidrug-Resistant .蒙花苷和金丝桃苷抑制lptD/msbA以破坏多重耐药菌的细胞膜
Biology (Basel). 2025 Aug 20;14(8):1087. doi: 10.3390/biology14081087.
2
An activator regulates the DNA damage response and anti-phage defense networks in Moraxellaceae.一种激活剂调节莫拉菌科中的DNA损伤反应和抗噬菌体防御网络。
Nucleic Acids Res. 2025 Aug 27;53(16). doi: 10.1093/nar/gkaf828.
3
High-throughput single-cell analysis reveals fully human Omp38-specific monoclonal antibodies against Acinetobacter baumannii.
高通量单细胞分析揭示了针对鲍曼不动杆菌的完全人源Omp38特异性单克隆抗体。
BMC Microbiol. 2025 Aug 20;25(1):523. doi: 10.1186/s12866-025-04283-y.
4
Synthesis of disaccharide and trisaccharide substructures of an A. baumannii lipooligosaccharide core.鲍曼不动杆菌脂寡糖核心的二糖和三糖亚结构的合成。
Carbohydr Res. 2025 Nov;557:109639. doi: 10.1016/j.carres.2025.109639. Epub 2025 Aug 7.
5
Orthopedic infections associated with distinct strains in rural area of Qingdao, China.中国青岛农村地区与不同菌株相关的骨科感染。
Front Cell Infect Microbiol. 2025 Jul 30;15:1601779. doi: 10.3389/fcimb.2025.1601779. eCollection 2025.
6
Phenotypic and genotypic analysis of isolated from combat wounds in Ukraine during 2022 and 2023.2022年和2023年从乌克兰战斗伤口分离出的[具体物质未提及]的表型和基因型分析。
JAC Antimicrob Resist. 2025 Aug 7;7(4):dlaf140. doi: 10.1093/jacamr/dlaf140. eCollection 2025 Aug.
7
DNA uptake and twitching motility are controlled by the small RNA Arp through repression of pilin translation in .DNA摄取和颤动运动性由小RNA Arp通过抑制菌毛蛋白翻译来控制。
bioRxiv. 2025 Jul 19:2025.07.19.665661. doi: 10.1101/2025.07.19.665661.
8
Amino acid competition shapes Acinetobacter baumannii gut carriage.氨基酸竞争影响鲍曼不动杆菌在肠道中的定植。
Cell Host Microbe. 2025 Aug 13;33(8):1396-1411.e9. doi: 10.1016/j.chom.2025.07.003. Epub 2025 Aug 4.
9
Interaction of an Acinetobacter baumannii's Membrane Protein with Human Fibronectin to Evade Immune Response.鲍曼不动杆菌膜蛋白与人纤连蛋白的相互作用以逃避免疫反应。
Chemistry. 2025 Aug 13;31(45):e00874. doi: 10.1002/chem.202500874. Epub 2025 Jul 25.
10
Exploring bladder cancer through urinary microbiota: innovative "urinetypes" classification and establishment of a diagnostic model.通过尿液微生物群探索膀胱癌:创新的“尿型”分类及诊断模型的建立
J Transl Med. 2025 Jul 22;23(1):809. doi: 10.1186/s12967-025-06518-y.